摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Acetyl-4-methyl-2,6-dimethoxy-benzol | 31405-67-1

中文名称
——
中文别名
——
英文名称
1-Acetyl-4-methyl-2,6-dimethoxy-benzol
英文别名
1-(2,6-dimethoxy-4-methyl-phenyl)-ethanone;1-(2,6-Dimethoxy-4-methyl-phenyl)-aethanon;2,6-Dimethoxy-4-methylacetophenon;1-(2,6-dimethoxy-4-methylphenyl)ethanone
1-Acetyl-4-methyl-2,6-dimethoxy-benzol化学式
CAS
31405-67-1
化学式
C11H14O3
mdl
——
分子量
194.23
InChiKey
PUIITOIZOJBGGN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:185fa6f493909cee10cec541c9c022db
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Lipase-mediated resolution of substituted 2-aryl-propanols: application to the enantioselective synthesis of phenolic sesquiterpenes
    摘要:
    A comprehensive study of the lipase-mediated resolution of substituted 2-aryl-propanols is reported. The latter alcohols were submitted to the irreversible acetylation catalyzed either by PPL, CRL, or lipase PS. The enantioselectivity of these transformations was dependent on the type of lipase used. The type of substituents and particularly their position on the aromatic ring strongly affected the selectivity of the reaction. The experiments described prove that PPL is the more versatile lipase catalyzing the acetylation with an enantiomeric ratio (E) value that ranges from 1 up to 144, depending on the substrate used. Conversely, the same transformations were catalyzed by CRL and lipase PS with an enantiomeric ratio value, which is always less than 5. The remarkable behavior of PPL was exploited in the large scale resolution of some substituted 2-aryl-propanols whose enantiomeric forms are relevant building blocks in the enantioselective synthesis of phenolic sesquiterpenes. By these means, the synthesis of (S)-turmeronol B and the formal syntheses of (R)-curcumene, (R)-curcuphenol, (R)-xanthorrhizol, and (R)-curcuhydroquinone were accomplished. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2011.03.012
  • 作为产物:
    参考文献:
    名称:
    Tambor, Chemische Berichte, 1908, vol. 41, p. 796
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Modulators Of HEC1 Activity And Methods Therefor
    申请人:Lau Johnson
    公开号:US20110230486A1
    公开(公告)日:2011-09-22
    Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Especially preferred compounds disrupt Nek2/Hec1 binding and are therefore useful as chemotherapeutic agent for neoplastic diseases.
    提供了用于调节Hec1/Nek2相互作用的化合物、组合物和方法。特别偏爱的化合物会破坏Nek2/Hec1的结合,因此可用作肿瘤疾病的化疗药物。
  • Über die Reaktion von 3,5-Diacetyl-2,6-dimethyl-4H-pyran-4-on mit Natriumalkanolaten
    作者:Fritz Eiden、Ernst-Günther Teupe
    DOI:10.1002/ardp.19813140307
    日期:——
    Die Reaktion von 3,5‐Diacetyl‐2,6‐dimethyl‐4H‐pyran‐4‐on (10) mit Natriummethanolat bzw. ‐ethanolat führt zu den 1‐Acetyl‐2‐hydroxy‐4‐methyl‐6‐alkoxybenzolen 11a und 11b.
    3,5-二乙酰-2,6-二甲基-4H-吡喃-4-酮 (10) 与甲醇钠或乙醇钠反应生成 1-乙酰基-2-羟基-4-甲基-6-烷氧基苯 11a 和11b.
  • MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR
    申请人:Taivex Therapeutics, Inc.
    公开号:US20150057281A1
    公开(公告)日:2015-02-26
    Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Especially preferred compounds disrupt Nek2/Hec1 binding and are therefore useful as chemotherapeutic agent for neoplastic diseases.
    提供了调节Hec1/Nek2相互作用的化合物、组合物和方法。特别优选的化合物破坏Nek2/Hec1结合并因此可用作肿瘤疾病的化疗药物。
  • [EN] COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY<br/>[FR] COMPOSÉS ET COMPOSITIONS POUR TRAITER DES ÉTATS PATHOLOGIQUES ASSOCIÉS À L'ACTIVITÉ DU RÉCEPTEUR LPA
    申请人:LHOTSE BIO INC
    公开号:WO2022083703A1
    公开(公告)日:2022-04-28
    This disclosure relates to LPA antagonists of Formula (I) : including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    该披露涉及LPA拮抗剂的公式(I):包括其药物可接受的盐和溶剂,以及包括这些盐和溶剂的药物组合物。
  • Hattori, Acta Phytochimica, 1928, vol. 4, p. 44,52
    作者:Hattori
    DOI:——
    日期:——
查看更多